EUVIMEDEUVIMED entdecken
Crossref

Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition

Qing Wang, Yangyang Peng, Shuna Wang, Jingjing Xu, Chiwen Cheng, Xiao Luo, Kang Yu, Wen Yao, Yijie Pi, Zeyu Zhu, Yifeng Yu

Journal of Ocular Pharmacology and Therapeutics · 2025

DOI: 10.1089/jop.2024.0162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Qing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Autophagy, Corneal Neovascularization, Angiogenesis Inhibitors, Pyrimidines. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to investigate the therapeutic potential of AZD6738, an ataxia-telangiectasia and rad3-related (ATR) kinase inhibitor, in preventing corneal neovascularization (CNV) by exploring its effects on autophagy regulation and angiogenesis.

Methods

Human umbilical vein endothelial cells were cultured and treated with varying concentrations of AZD6738 and vascular endothelial growth factor (VEGF) to assess cell viability, migration, and tube formation. A corneal alkali burn model in Sprague-Dawley rats was established to evaluate the in vivo effects of AZD6738 on CNV. Autophagy was assessed using monodansylcadaverine (MDC) staining, western blotting, and qRT-PCR to measure the expression of autophagy-related markers and key proteins involved in the PI3K-AKT pathway. Immunohistochemistry and immunofluorescence staining were employed to examine histological changes and the expression of markers related to neovascularization and fibrosis.

Results

The study demonstrated that AZD6738 significantly inhibited cell viability in a dose-dependent manner. AZD6738 effectively reduced VEGF-induced cell migration and tube formation. Moreover, the introduction of AZD6738 enhanced autophagy, as indicated by increased MDC staining, upregulated Beclin1 expression, and an elevated LC3 II/I ratio. The inhibitor also suppressed the PI3K-AKT pathway, reducing VEGF and VEGFR2 expression, and decreasing the phosphorylation levels of AMPK and AKT. In an experimental CNV model, AZD6738 treatment resulted in a significant reduction in CNV, with fewer and shorter blood vessels observed, as well as changes in autophagy-related proteins.

Conclusions

AZD6738 showed potential in preventing CNV. Its ability to enhance autophagy and inhibit PI3K-AKT-VEGF pathways in angiogenesis suggests that AZD6738 could be an effective treatment strategy for CNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyCorneal NeovascularizationAngiogenesis InhibitorsPyrimidinesAnimalsRats, Sprague-DawleyRatsHumansHuman Umbilical Vein Endothelial CellsCell SurvivalVascular Endothelial Growth Factor ACell MovementMaleDisease Models, AnimalDose-Response Relationship, DrugAngiogenesis

Stichwörter der Autor:innen

ATR kinaseAZD6738PI3K/AKTautophagycornea neovascularization

Substanzen

Angiogenesis InhibitorsPyrimidinesVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Yingtan People's Hospital, Yingtan City, China.
  • Heyou Hospital, Foshan City, China.

Zitieren

APA

Wang, Q., Peng, Y., Wang, S., Xu, J., Cheng, C., Luo, X., Yu, K., Yao, W., Pi, Y., Zhu, Z., & Yu, Y. (2025). Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0162

Vancouver

Wang Q, Peng Y, Wang S, Xu J, Cheng C, Luo X, et al. Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2024.0162

BibTeX
@article{Wang2025,
  author = {Wang, Qing and Peng, Yangyang and Wang, Shuna and Xu, Jingjing and Cheng, Chiwen and Luo, Xiao and Yu, Kang and Yao, Wen and Pi, Yijie and Zhu, Zeyu and Yu, Yifeng},
  title = {Exploring the Efficacy of AZD6738 in Corneal Neovascularization: Autophagy Enhancement and Angiogenesis Inhibition},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1089/jop.2024.0162}
}
Kostenlos starten →